Ibex Medical Analytics is the pioneer in applying computational pathology to cancer diagnostics.
Pathologists are challenged to provide accurate and timely analysis as the number of tests increases year-over-year. Ibex uses artificial intelligence (AI) to develop clinical-grade algorithms that detect cancer as accurately as a human pathologist.
Ibex’s product suite uses the algorithms to analyse images, detect and grade cancer in biopsies, helping pathologists reduce diagnostic error rates and enable a more efficient workflow.
Deployed worldwide, Ibex’s solution is the first-ever AI-powered cancer diagnostic solution in routine clinical practice in pathology labs, with demonstrated success in detecting missed cancer cases.
We are a multidisciplinary team of entrepreneurs, data scientists, software engineers and medical experts, working together to realize our vision: applying AI to cancer diagnostics, striving to improve patient outcomes and quality of life.
If you are an outstanding professional constantly looking for challenges, passionate about your work, a team player and want to feel that you are making a difference – we want to hear from you.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2016
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Ibex Medical Analytics founded?
Ibex Medical Analytics was founded in 2016.
What industry is Ibex Medical Analytics in?
Ibex Medical Analytics operates in Hospital & Health Care. Find similar Hospital & Health Care investors on gritt.io.
Where is Ibex Medical Analytics based?
Ibex Medical Analytics is headquartered in Tel Aviv, Israel.
Find investors for your startup like Ibex Medical Analytics
Gritt sends AI-personalised outreach to each investor — from your Gmail